Seventy-seven patients presenting for outpatient cystoscopy participated in a trial to assess postoperative recovery when either a/fentanil, halothane, or enflurane were used in combination with nitrous oxide/oxygen anaesthesia. Anaesthesia was uneventful in all cases. Apnoea occurred once with a/fentanil, but naloxone was not required. Vomiting occurred once with a/fentanil and once with enflurane. Anti-emetics were not required. Blood pressure and pulse rate variations from preoperative levels occurred with similar frequency in all groups. Times to open eyes, show left thumb, and give correct date of birth were significantly less with a/fentanil than with the other agents tested. Trieger testing failed to demonstrate an advantage of a/fentanil, although two patients in each of the halothane and enflurane groups were insufficiently recovered to complete the tests. As tested, a/fentanil represents a useful alternative to halothane or enflurane as postoperative recovery of mental function is significantly more rapid than with the inhalational agents.
It was decided to compare maintenance and recovery characteristics of two available agents with the new synthetic opioid analgesic, alfentanil.
Alfentanil is a tetrazole derivative of fentanyl, with higher protein-binding and less lipid solubility than the latter compound, resulting in a smaller distribution volume, and shorter elimination half-life (94 minutes, compared with 200 minutes for fentanyl). These characteristics result in a drug with rapid onset, little accumulation on repeated dosage, short duration of action, and rapid recovery. [3] [4] [5] [6] MATERIAL AND METHOD Hospital Ethics Committee approval was granted for the study, in which seventy-seven patients participated. Inclusion criteria were any patient between 15 and 85 years of age, ASA I or 11, 7 and with no documented allergy to any of the agents to be used. Each patient gave written consent to take part in the study. Patients were randomly allocated to one of the three groups -halothane (I), alfentanil (11), or enflurane (Ill). No patient received premedication. Those patients receiving inhalation supplements were induced with sodium thiopentone 2.5%, until loss of eyelash reflex, followed by halothane 0.5-2%, or enflurane 1-3%, as required, in combination with nitrous oxide 66% in oxygen 33%. Those patients receiving alfentanil were given a bolus dose of 7 !J.glkg, over 30 seconds, immediately prior to anaesthetic induction with thiopentone and supplementary doses of 3.5 !J.glkg if any of the following occurred: diaphoresis, lacrimation, increased depth of respiration or a 20% or more increase in systolic blood pressure above the preinduction value. Routine monitoring included non-invasive oscillometric blood pressure estimations at three-minute intervals using a Oinamap 1846 Vital Signs Monitor (Critikon Inc., Tampa, F1.), and continuous electrocardiography utilising a Medtel HS 1 0 (Medtel Australia, Sydney, N.S.W.). Note was taken of the occurrence of any of the following: excursion of the blood pressure or heart rate more than 20% either way from the pre-anaesthetic value, apnoea of longer than 20 seconds requiring assisted ventilation, emesis and use of either antiemetics or naloxone.
Recovery times were taken from discontinuation of nitrous oxide to times for opening eyes, showing left thumb, and giving correct date of birth, while estimation of mental function included the performance of a modified Trieger test. 8 ,9 Performance of the Trieger test required the patient to join a series of dots spaced 12 mm apart on a preprepared figure. Scoring of the test involved summating the distances in millimetres from the centre of the dots missed, and by the line omitted. Statistical analysis of the raw data was performed using the ANOV A Package 10 on an Apple Macintosh microcomputer.
RESULTS

Demographic data.
Patients were well-balanced with respect to demographic data: Of the seventy-seven patients, twenty-six received halothane, twenty-six received alfentanil, and twentyfive received enflurane. The three groups of patients had a similar range of ages: 45.0 (SO 15.8) years; 51.5 (SO 17.5) years and 51.7 (SO 14.1) years respectively (P=0.24), and weights: 70.1 (SO 9.9) kg; 69.0 (SO 9.8) kg and 70.0 (SO 11.7) kg respectively (P= 0.92). The sex breakdown by experimental group shows that the groups were not statistically different: M13:F13; M:17:F:9; and M11:F14 for the halothane, alfentanil and enflurane groups respectively. (Pearson Chi-square = 2.51, P= 0.29).
Duration of anaesthesia and surgery.
For the three groups anaesthetic times were as follows: 11.3 (SO 7.9) minutes; 10.0 (SO 2.5) minutes and 10.8 (SO 3.0) minutes for halothane, alfentanil, and enflurane respectively (P = 0.63). Surgical times were also comparable: 8.6 (SO 7.9) minutes; 6.4 (SO 2.4) minutes and 7.8 (SO 2.6) minutes repsectively (P = 0.27).
Outcome measures.
The three main outcome measures -time (in minutes) to open eyes (OPEN), time to Tukey's HSD multiple comparison procedure ll was used to determine the means between which significant differences existed. The Tukey's HSD tests were computed keeping the overall alpha level at 0.05. Table 2 Summarises these results.
For OPEN, it was found that the three groups were significantly different from each other. The alfentanil group was significantly quicker on average to open eyes than the enflurane group which in turn was significantly quicker on average to open eyes than the halothane group. The alfentanil was much quicker than the halothane group.
For THUMB, it was found that group I (halothane) was significantly different from both group II (alfentanil) and group III (enflurane). Groups II and III were not significantly different from each other. The halothane group was significantly slower on average to show their left thumb than either of the other two groups. While the alfentanil group was quicker on average to show their left thumb than the enflurane group, the difference is not significant.
This pattern of significance was also found for BIRTH. For BIRTH, the halothane group was significantly different from both the alfentanil and enflurane groups: however, the multiple comparisons revealed that the alfentanil and enflurane groups did not differ significantly. Once again, the halothane group was significantly slower to recall their correct date of birth than either the alfentanil or enflurane groups. The alfentanil group was slightly quicker in recalling their date of birth when compared with the enflurane group, but the difference is not significant. Table 3 summarises the scores for the Trieger test. Although there is no difference between the groups at the beginning of the trial, there appears to be a difference at the ten minutes post-anaesthetic point and again at the 60-minute point, although not at the 20-minute point. However, individual variance was sufficiently great to make meaningful comparisons difficult. A further problem with the results of the Trieger test is due to some patients being insufficiently alert to complete the test. At ten minutes, two patients in the enflurane group and four patients in the halothane group were unable to complete the test, while at twenty minutes two patients in each of the enflurane and halothane groups were unable to complete the test. The omission of these patients biases the results in favour of those groups. Interestingly, all patients receiving alfentanil were able to complete the test at each time value. 
Adverse responses
Adverse responses included the occurrence of emesis, respiratory depression, or changes in pulse rate or blood pressure in excess of20% of the pre-induction value. In the halothane group, twelve patients exhibited variations in pulse or systolic blood pressure of 20% or less, while fourteen exhibited variations of more than 20%. In the case of alfentanil, the respective numbers were :S::20%: 19; > 20%: 1 7 and for enflurane :S::20%:8; > 20%: 1 7.
(Pearson Chi-square 1.24, P= 0.54.) DISCUSSION All patients were noted to have experienced a satisfactory anaesthetic without any serious adverse reaction. There were no major problems at either induction, maintenance, or recovery, and vomiting was unusual, unlike the experience of others. 12 A significant difference was found between the three groups on the time to recovery measures. For both the time to open eyes and the time to show left thumb, the alfentanil group, on average, required significantly less time that the halothane or enflurane groups. For the time to correct date of birth, the alfentanil and enflurane groups both required significantly less time than the halothane group. These differences were unrelated to the age and weight characteristics of the patient. Other authors have also found recovery with alfentanil to be more rapid than with halothane l3 • 15 or enflurane. 12 The results of the Trieger test, which was intended to demonstrate differences in the quality of recovery, were inconclusive. The Trieger test (a form of paper and pencil test) itself is a modification by Newman, Trieger and Miller, of Bender's Motor Gestalt test which was originally used in World War 11 to discover cases of abnormal cerebral function in Army Medical installations, 1 and later as an aid in diagnosis and psychotherapy in children with organic brain damage. 9 Cooper states that 'paper and pencil tests such as these . .. are considered to be suitable tests indicating that the patient is fit to go home'.
Kortilla 16 also made the observations that awakening, immediate clinical recovery and fitness to go home are easily quantified by a single test but that further assessment of recovery requires more than one test.
In summary, for patients presenting for outpatient urology requiring general anaesthesia, alfentanil represents a useful alternative to inhalation supplementation, as cardiovascular stability is maintained. Emesis and respiratory depression are no more common than with other techniques, and early postoperative recovery of mental function is significantly more rapid than with either halothane or enflurane.
